Logo Universal Health Services

Universal Health Services (UHS) stock: analyst price target and their real reliability

Live quote · data updated Oct 14, 2026
Universal Health Services · Health Care · ref. ETF XLV · 50 calls · price $179.01
💬JPI AI AssistantTry it →
What the company does: Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States.

📈 Universal Health Services (UHS) stock price

$179.01-12.2% over range
Oct 14, 25low $141.17 · high $244.18Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
36% recommend buying · 11 analysts
📊 JPI status : Universal Health Services has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 UHS price target & analyst consensus — price $179

The price target · all analysts combined (11 targets)
Highest target · 1 firm of 11$310+73.2%
Median target · of 11 targets$190+6.1%
Lowest target · 2 firms of 11$166-7.3%
Current price$179.01
Where these 11 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 873% $183 ↔ $310
Below 327% $166 ↔ $168
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (830 calls tested). It aims for $191 (+6.7 %), call made on July 30, 2026, maturing on July 30, 2027 (76 d ago).

The 6 reliable analysts $190+5.8 %
The 5 other firms $194+8.4 %
How to read it: the 6 reliable firms are not filtered by optimism — 4 aim above the price, 2 below, hence their $190 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 11 ratings (last 6 months)
Strong Buy00%
Buy436%
Hold764%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Universal Health Services? The JPI assistant answers using our backtest data.

💰 Universal Health Services dividend: yield, history & growth › open the full page

0.53%annual yield
That's ~$0.80 per share per year.

📈 Universal Health Services fundamentals: valuation, margins & growth › open the full page

P/E 7.3Net margin 8.4 %Revenue growth +8.3 %Cheap for the growth

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 5 %
2023
Rev +7%Profit +6%
2024
Rev +11%Profit +59%
2025
Rev +10%Profit +30%

🔎 Detailed analyses

✅ Historical analyst reliability on UHS

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕ % right i ↕ Gain vs sector i ↕ Calls i ↕
Standpoint Research 100% +39.4% 2
Leerink Swann 100% +15.2% 2
Credit Suisse 88% +27.2% 17
B of A Securities ↗ 80% +15.9% 10
BMO Capital ↗ 80% +14.7% 5
Deutsche Bank ↗ 75% +19.9% 20
Citigroup ↗ 75% +15.6% 12
TD Cowen ↗ 67% +5.5% 3
JP Morgan ↗ 60% +15.5% 5
Barclays ↗ 57% +10.1% 21
See the other 7 firms
Baird ↗ 25% -9.0% 4
Cantor Fitzgerald ↗ 44% -9.1% 9
Goldman Sachs ↗ 50% -2.6% 12
Keybanc ↗ 50% +23.1% 2
Mizuho ↗ 53% +10.4% 15
Wells Fargo ↗ 54% -0.2% 13
UBS ↗ 54% +3.7% 13

📊 What $1,000 invested in Universal Health Services would be worth › open the full page

In short — $1,000 invested in Universal Health Services 10 years ago would be worth $1,244 today, i.e. +2%/yr on average. Best year: 2019 (+23%), worst: 2016 (-11%). Price performance, excluding dividends.

If I'd invested $1,000 in Universal Health Services

InvestmentWorth todayGain
1 years ago$829-17%
3 years ago$1,055+6%
5 years ago$1,081+8%
→ See Universal Health Services's full return history + gain calculator

Return by year (Universal Health Services)

YearReturn$1,000 invested at year start
2026 (YTD)-32%$682 (-32%)
2025+22%$829 (-17%)
2024+18%$975 (-2%)
→ See Universal Health Services's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Universal Health Services

Loading news…

📋 All analyst calls on UHS

▲ Outperform · 🎯$205
Price at call : $176.69 — upside +16%
Today : $179.01 — upside +15%
🎯 on UHS : no call matured yet · 📊 on Health : 53.7% · -6.2% (41 calls)
in progress (365j)
matures : Sep 18, 27
RBC Capital ↗
Aug 20, 26
■ Sector Perform neutral · not a buy · 🎯$183
Price at call : $177.26 — gap to target +3%
Today : $179.01 — gap to target +2%
🎯 on UHS : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Aug 20, 27
RBC Capital ↗
Aug 3, 26
■ Sector Perform neutral · not a buy · 🎯$183
Price at call : $167.87 — gap to target +9%
Today : $179.01 — gap to target +2%
🎯 on UHS : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Aug 3, 27
Goldman Sachs ↗
Jul 30, 26
■ Neutral neutral · not a buy · 🎯$190
Price at call : $168.44 — gap to target +13%
Today : $179.01 — gap to target +6%
🎯 on UHS : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Jul 30, 27
Morgan Stanley ↗
Jul 29, 26
■ Equal-Weight neutral · not a buy · 🎯$191
Price at call : $163.29 — gap to target +17%
Today : $179.01 — gap to target +7%
🎯 on UHS : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Jul 29, 27
Guggenheim ↗
Jul 29, 26
▲ Buy · 🎯$189
Price at call : $163.29 — upside +16%
Today : $179.01 — upside +6%
🎯 on UHS : 100% (1 call matured) · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Jul 29, 27
■ Neutral neutral · not a buy · 🎯$194
Price at call : $168.16 — gap to target +15%
Today : $179.01 — gap to target +8%
🎯 on UHS : no call matured yet · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Jul 29, 27
Baird ↗
Jul 29, 26
■ Neutral neutral · not a buy · 🎯$166
Price at call : $168.16 — gap to target -1%
Today : $179.01 — gap to target -7%
🎯 on UHS : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Jul 29, 27
See the other 42 calls, newest to oldest
■ Neutral neutral · not a buy · 🎯$194
Price at call : $166.22 — gap to target +17%
Today : $179.01 — gap to target +8%
🎯 on UHS : no call matured yet · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Jul 28, 27
Barclays ↗
Jul 28, 26
■ Equal-Weight neutral · not a buy · 🎯$168
Price at call : $166.22 — gap to target +1%
Today : $179.01 — gap to target -6%
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jul 28, 27
Guggenheim ↗
Jul 20, 26
▲ Buy · 🎯$195
Price at call : $150.64 — upside +29%
Today : $179.01 — upside +9%
🎯 on UHS : 100% (1 call matured) · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Jul 20, 27
Wells Fargo ↗
Jul 13, 26
■ Equal-Weight neutral · not a buy · 🎯$166
Price at call : $152.77 — gap to target +9%
Today : $179.01 — gap to target -7%
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jul 13, 27
Barclays ↗
Jul 8, 26
■ Equal-Weight neutral · not a buy · 🎯$179
Price at call : $156.43 — gap to target +14%
Today : $179.01 — gap to target -0%
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jul 8, 27
TD Cowen ↗
Jun 22, 26
▲ Buy · 🎯$197
Price at call : $145.85 — upside +35%
Today : $179.01 — upside +10%
🎯 on UHS : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jun 22, 27
UBS ↗
Apr 30, 26
▲ Buy · 🎯$310
Price at call : $167 — upside +86%
Today : $179.01 — upside +73%
🎯 on UHS : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Apr 30, 27
TD Cowen ↗
Apr 29, 26
▲ Buy · 🎯$230
Price at call : $168.27 — upside +37%
Today : $179.01 — upside +28%
🎯 on UHS : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Apr 29, 27
RBC Capital ↗
Apr 29, 26
■ Sector Perform neutral · not a buy · 🎯$190
Price at call : $168.27 — gap to target +13%
Today : $179.01 — gap to target +6%
🎯 on UHS : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Apr 29, 27
Guggenheim ↗
Apr 29, 26
▲ Buy · 🎯$211
Price at call : $168.27 — upside +25%
Today : $179.01 — upside +18%
🎯 on UHS : 100% (1 call matured) · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Apr 29, 27
■ Neutral neutral · not a buy · 🎯$194
Price at call : $168.27 — gap to target +15%
Today : $179.01 — gap to target +8%
🎯 on UHS : no call matured yet · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Apr 29, 27
Baird ↗
Apr 29, 26
■ Neutral neutral · not a buy · 🎯$204
Price at call : $167.97 — gap to target +21%
Today : $179.01 — gap to target +14%
🎯 on UHS : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Apr 29, 27
Barclays ↗
Apr 28, 26
▲ Overweight · 🎯$238
Price at call : $167.97 — upside +42%
Today : $179.01 — upside +33%
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 28, 27
Wells Fargo ↗
Mar 2, 26
■ Equal-Weight neutral · not a buy · 🎯$212
Price at call : $204.85 — gap to target +3%
Today : $179.01 — gap to target +18%
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Mar 2, 27
■ Neutral neutral · not a buy · 🎯$229
Price at call : $206.42 — gap to target +11%
Today : $179.01 — gap to target +28%
🎯 on UHS : no call matured yet · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Feb 27, 27
Barclays ↗
Feb 26, 26
▲ Overweight · 🎯$268
Price at call : $206.1 — upside +30%
Today : $179.01 — upside +50%
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 26, 27
Barclays ↗
Jan 22, 26
▲ Overweight · 🎯$262
Price at call : $205.09 — upside +28%
Today : $179.01 — upside +46%
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jan 22, 27
TD Cowen ↗
Jan 7, 26
▲ Buy · 🎯$245
Price at call : $211.14 — upside +16%
Today : $179.01 — upside +37%
🎯 on UHS : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jan 7, 27
Wells Fargo ↗
Jan 7, 26
■ Equal-Weight neutral · not a buy · 🎯$235
Price at call : $211.14 — gap to target +11%
Today : $179.01 — gap to target +31%
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jan 7, 27
Guggenheim ↗
Dec 2, 25
▲ Buy · 🎯$274
Price at call : $238.68 — upside +15%
Today : $179.01 — upside +53%
🎯 on UHS : 100% (1 call matured) · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Dec 2, 26
Wells Fargo ↗
Nov 13, 25
▲ Overweight · 🎯$259
Price at call : $225.04 — upside +15%
Today : $179.01 — upside +45%
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Nov 13, 26
RBC Capital ↗
Oct 30, 25
■ Sector Performer neutral · not a buy · 🎯$231
Price at call : $217.01 — gap to target +6%
Today : $179.01 — gap to target +29%
🎯 on UHS : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Oct 30, 26
UBS ↗
Oct 29, 25
▲ Buy · 🎯$302
Price at call : $218.69 — upside +38%
Today : $179.01 — upside +69%
🎯 on UHS : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Oct 29, 26
■ Neutral neutral · not a buy · 🎯$250
Price at call : $218.69 — gap to target +14%
Today : $179.01 — gap to target +40%
🎯 on UHS : no call matured yet · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Oct 29, 26
Guggenheim ↗
Oct 29, 25
▲ Buy · 🎯$253
Price at call : $225.3 — upside +12%
Today : $179.01 — upside +41%
🎯 on UHS : 100% (1 call matured) · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Oct 29, 26
Barclays ↗
Oct 28, 25
▲ Overweight · 🎯$263
Price at call : $219.32 — upside +20%
Today : $179.01 — upside +47%
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 28, 26
Wells Fargo ↗
Oct 7, 25
▲ Overweight · 🎯$249
Price at call : $205.2 — upside +21%
Today : $179.01 — upside +39%
Expected +21% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
-14.4%
stock -14% · XLV +16%
matured Oct 7, 26
■ Neutral neutral · not a buy · 🎯$227
Price at call : $209.7 — gap to target +8%
Today : $179.01 — gap to target +27%
🎯 on UHS : no call matured yet · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Oct 7, 26
Barclays ↗
Sep 18, 25
▲ Overweight · 🎯$250
Price at call : $188.11 — upside +33%
Today : $179.01 — upside +40%
Expected +33% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-6.1%
stock -6% · XLV +22%
matured Sep 18, 26
■ Neutral neutral · not a buy · 🎯$227
Price at call : $181.45 — gap to target +25%
Today : $179.01 — gap to target +27%
🎯 on UHS : no call matured yet · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Aug 26, 26
RBC Capital ↗
Aug 19, 25
■ Sector Perform neutral · not a buy · 🎯$206
Price at call : $184.7 — gap to target +12%
Today : $179.01 — gap to target +15%
🎯 on UHS : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Aug 19, 26
Baird ↗
Aug 14, 25
■ Neutral neutral · not a buy · 🎯$203
Price at call : $178.47 — gap to target +14%
Today : $179.01 — gap to target +13%
🎯 on UHS : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Aug 14, 26
Wells Fargo ↗
Aug 14, 25
▲ Overweight · 🎯$210
Price at call : $178.47 — upside +18%
Today : $179.01 — upside +17%
Expected +18% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
-4.5%
stock -4% · XLV +23%
matured Aug 14, 26
JP Morgan ↗
Aug 4, 25
■ Neutral neutral · not a buy · 🎯$195
Price at call : $164.7 — gap to target +18%
Today : $179.01 — gap to target +9%
🎯 on UHS : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Aug 4, 26
Barclays ↗
Jul 30, 25
▲ Overweight · 🎯$259
Price at call : $166.45 — upside +56%
Today : $179.01 — upside +45%
Expected +56% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+1.2%
stock +1% · XLV +25%
matured Jul 30, 26
▼ Underperform · 🎯$185
Price at call : $170.28 — upside +9%
Today : $179.01 — upside +3%
Expected +9% · Actual -10% · Reason (≤ −15%) : ✗ No
🎯 on UHS : 100% (1 call matured) · 📊 on Health : 48.1% · +2.0% (362 calls)
+9.8%
stock -10% · XLV +21%
matured Jul 16, 26
RBC Capital ↗
Apr 30, 25
■ Sector Perform neutral · not a buy · 🎯$201
Price at call : $174.63 — gap to target +15%
Today : $179.01 — gap to target +12%
🎯 on UHS : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Apr 30, 26
Barclays ↗
Apr 29, 25
▲ Overweight · 🎯$257
Price at call : $171.88 — upside +50%
Today : $179.01 — upside +44%
Expected +50% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-2.3%
stock -2% · XLV +3%
matured Apr 29, 26
Baird ↗
Apr 15, 25
■ Neutral neutral · not a buy · 🎯$224
Price at call : $175.5 — gap to target +28%
Today : $179.01 — gap to target +25%
🎯 on UHS : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Apr 15, 26
Guggenheim ↗
Apr 9, 25
▲ Buy · 🎯$208
Price at call : $178.24 — upside +17%
Today : $179.01 — upside +16%
Expected +17% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on UHS : 100% (1 call matured) · 📊 on Health : 55.4% · +4.9% (101 calls)
+1.4%
stock +1% · XLV +9%
matured Apr 9, 26
Morgan Stanley ↗
Mar 26, 25
■ Equal-Weight neutral · not a buy · 🎯$200
Price at call : $184.46 — gap to target +8%
Today : $179.01 — gap to target +12%
🎯 on UHS : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Mar 26, 26
Wells Fargo ↗
Mar 10, 25
▲ Overweight · 🎯$225
Price at call : $172.52 — upside +30%
Today : $179.01 — upside +26%
Expected +30% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on UHS : 33% (3 calls matureds) · 📊 on Health : 47.6% · +1.0% (403 calls)
+8.0%
stock +8% · XLV +5%
matured Mar 10, 26

Frequently asked questions

Should I buy Universal Health Services stock?

This isn't buy advice. For Universal Health Services, the analyst consensus is "Hold", with an average price target of $190 (+6% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Universal Health Services). We show the numbers — you decide.

Is it too late to buy Universal Health Services? How high can it go?

The most bullish analyst target on Universal Health Services is $310 (+73% above today's price); the average is $190. That's the upside they see. Check how reliable those analysts have actually been on Universal Health Services on our site before trusting it.

Is Universal Health Services still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 17 analysts have a real record on Universal Health Services, the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.

Should you invest in Universal Health Services? The case for and against

The arguments for and against, one by one, from the numbers: why invest in UHS (and why hesitate).

What has Universal Health Services's past performance been?

Historical returns and a "how much if I had invested" calculator: UHS performance & returns.

Does Universal Health Services pay a dividend?

Yield, consistency and growth history of the dividend: UHS's dividend.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)